If the companies' exclusivities which are still in the pipeline like Diovan and Valcyte are from this plant then there can be significant financial impact, says Sriram Rathi.
first published: Sep 16, 2013 09:41 am
A collection of the most-viewed Moneycontrol videos.
Indian stocks Vs Gold, Silver, Global equities: Manish Chokhani on where to sow, where to harvest
Can Nifty Reclaim 25,400 After Strong Comeback; Infosys, Axis, Eternal In Focus|Opening Bell Live
Sensex, Nifty resume rally after 2-day pause, financials shine bright | Closing Bell
Maran Govindasamy of Unifi Capital on Investment Insights from India’s Consumption Story
